<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-4ZJMGFE4</identifier><date>2023</date><creator>Peternel Pečauer, Helena</creator><relation>documents/doc/4/URN_NBN_SI_doc-4ZJMGFE4_001.pdf</relation><relation>documents/doc/4/URN_NBN_SI_doc-4ZJMGFE4_001.txt</relation><format format_type="type">article</format><format format_type="issue">letn. 33</format><format format_type="extent">str. 28-31</format><identifier identifier_type="ISSN">0353-782X</identifier><identifier identifier_type="COBISSID_HOST">140939267</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-4ZJMGFE4</identifier><language>slv</language><publisher publisher_location="Ljubljana">Mladinska knjiga</publisher><source>Gea (Ljubljana)</source><rights>InC</rights><subject language_type_id="slv">celično zdravljenje</subject><subject language_type_id="slv">dejavniki tveganja</subject><subject language_type_id="slv">imunoterapija</subject><subject language_type_id="slv">prostata</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="slv">rak prostate</subject><subject language_type_id="slv">simptomi</subject><subject language_type_id="slv">zdravljenje</subject><title>"Slovensko" zdravilo</title></Record>